Asan Medical Center: Neoplasms trials
The registry lists 16 Neoplasms studies with Asan Medical Center as lead sponsor. 2 are open to participants now and 0 have results posted.
Phase 1 1Phase 2 4Phase 4 2No phase 10(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- The Effect of ERAS on Pancreaticoduodenectomy (v2.0)Not yet recruitingNCT06009224Not applicable
- A Phase II Stydy of Bevacizumab Plus Erlotinib in Patients for Krebs Cycle Altered CancerRecruitingNCT05904457Phase 2
- Beneficial Effect of Pulmonary Rehabilitation in Lung Cancer Patients Receiving Radiation TherapyStatus unknownNCT05414188Not applicable
- Ultrasound-assisted Thoracic Epidural Catheter InsertionCompletedNCT03890640Not applicable
- Treatment of Colorectal Liver Metastases With Immunotherapy and BevacizumabCompletedNCT03698461Phase 2
- Effect of PEEP on Arterial Oxygen Partial Pressure in Elderly Patients With Lithotomy Position Using LMA Supreme™CompletedNCT03390127Not applicable
- Clinical Outcomes of Preoperative and Postoperative Rehabilitation in the Patients With HBP MalignancyCompletedNCT02784353Not applicable
- Validation of 3 Dimensional Laparoscopic System in Disral Pancreatectomy and SplenectomyCompletedNCT02757690Phase 4
- The Efficacy of Tachosil® for Prevention of Hemorrhage After Loop Electrosurgical Excisional Procedure (LEEP)Status unknownNCT02629510Phase 4
- Intraductal Papillary Mucinous Neoplasm With Malignant ChangeTerminatedNCT02044926
- Serum Cholesterol and Gastric NeoplasmStatus unknownNCT02041312
- Brief Title : Optimized Endoscopic Submucosal Dissection With Snaring for Colorectal NeoplasmStatus unknownNCT01944540Not applicable
- Sorafenib Trial in Advanced and/or Recurrent Gastric Adenocarcinoma: Treatment Evaluation: STARGATECompletedNCT01187212Phase 2
- Voriconazole Trough Plasma Levels : Genetic Polymorphism, Efficacy, Safety in Patients With Hematologic MalignancyTerminatedNCT01148160
- Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced CancerCompletedNCT00823524Phase 1/2
- Donor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other DiseaseCompletedNCT00521430Not applicable